143 related articles for article (PubMed ID: 19164221)
1. A proposition for the use of radioiodine in WDTC management.
Bourgeois P
J Nucl Med; 2009 Feb; 50(2):328-9; author reply 329-30. PubMed ID: 19164221
[No Abstract] [Full Text] [Related]
2. Papillary carcinoma simultaneously involving thyroid, neck lymph-nodes, ovary and bone marrow.
Giovanella L; Suriano S; Ceriani L; Verburg FA
Nuklearmedizin; 2010; 49(6):N66-8. PubMed ID: 21140033
[No Abstract] [Full Text] [Related]
3. Thymus accumulation of I-131 after therapeutic dose for thyroid carcinoma.
Muratet JP; Giraud P
Clin Nucl Med; 1996 Sep; 21(9):736-7. PubMed ID: 8879880
[No Abstract] [Full Text] [Related]
4. Tumor thrombus in the great veins from papillary carcinoma of the thyroid: 131I scan findings.
Mugunthan N; Kumar AR; Thomas P
J Clin Endocrinol Metab; 2010 Jun; 95(6):2527-8. PubMed ID: 20525903
[TBL] [Abstract][Full Text] [Related]
5. Treatment of persistent or recurrent papillary carcinoma of the thyroid--the good, the bad, and the unknown.
Udelsman R
J Clin Endocrinol Metab; 2010 May; 95(5):2061-3. PubMed ID: 20444934
[No Abstract] [Full Text] [Related]
6. An aggressive radio-resistant papillary thyroid cancer.
Mehta RS; Negin B; Popii V; Langer C
Clin Adv Hematol Oncol; 2008 Oct; 6(10):761-7. PubMed ID: 18997667
[No Abstract] [Full Text] [Related]
7. Rectus abdominis muscle metastasis from papillary thyroid cancer identified by I-131 SPECT/CT.
Zhao LX; Li L; Li FL; Zhao Z
Clin Nucl Med; 2010 May; 35(5):360-1. PubMed ID: 20395716
[No Abstract] [Full Text] [Related]
8. Radioiodine therapy for thyroid cancer depicted uterine leiomyoma.
Hirata K; Shiga T; Kubota KC; Okamoto S; Kamibayashi T; Tamaki N
Clin Nucl Med; 2009 Mar; 34(3):180-1. PubMed ID: 19352287
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma.
Salvatori M; Luster M
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):821-8. PubMed ID: 20186542
[No Abstract] [Full Text] [Related]
10. [Thymic uptake of 18FFDG following radioiodine ablation therapy].
Albalá González MD; Martínez Gimeno E; Cárdenas Negro C; Allende Riera A; Cabello García D; De Sequera Rahola M; Uña Gorospe JA
Rev Esp Med Nucl; 2011; 30(5):314-6. PubMed ID: 21342725
[TBL] [Abstract][Full Text] [Related]
11. Bilateral renal metastases from papillary thyroid carcinoma on post 131I treatment scan: flip-flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation.
Borde C; Basu S; Kand P; Arya S; Shet T
Hell J Nucl Med; 2011; 14(1):72-3. PubMed ID: 21512673
[No Abstract] [Full Text] [Related]
12. [Papillary cancer of the thyroid: biological behaviour and therapeutic planning (author's transl)].
Spreafico G; Colombo L; Puricelli G
Radiol Med; 1978 Sep; 64(9):1005-20. PubMed ID: 749025
[TBL] [Abstract][Full Text] [Related]
13. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
14. [Radioiodine in the treatment of generalized papillary and follicular thyroid carcinoma].
Mäenpää H
Duodecim; 2014; 130(6):573-9. PubMed ID: 24724456
[TBL] [Abstract][Full Text] [Related]
15. An unusual presentation of diffuse sclerosing variant of papillary thyroid carcinoma.
Regalbuto C; Tumminia A; Malandrino P; Salamone S; Pezzino V
J Endocrinol Invest; 2010 Jun; 33(6):434-5. PubMed ID: 20631495
[No Abstract] [Full Text] [Related]
16. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.
Bonnet S; Hartl D; Leboulleux S; Baudin E; Lumbroso JD; Al Ghuzlan A; Chami L; Schlumberger M; Travagli JP
J Clin Endocrinol Metab; 2009 Apr; 94(4):1162-7. PubMed ID: 19116234
[TBL] [Abstract][Full Text] [Related]
17. Coregistered iodine-131 single photon emission computed tomography/computed tomography reveals dedifferentiation in a metastatic follicular thyroid carcinoma.
Walter MA; Wild D; Rasch H; Müller-Brand J; Müller B; Bilz S
Thyroid; 2006 Oct; 16(10):1063-4. PubMed ID: 17042695
[No Abstract] [Full Text] [Related]
18. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
19. Papillary microcarcinoma of the thyroid.
Shaha AR; Tuttle RM; Shah JP
J Surg Oncol; 2007 Jun; 95(7):532-3. PubMed ID: 17192917
[No Abstract] [Full Text] [Related]
20. [Incidental detection of a papillary thyroid cancer by ¹⁸F-FDG PET-CT study in a patient with metastatic colorectal cancer].
Banzo J; Ubieto MA; Villalta J; Razola P; Prats E; Andrés A
Rev Esp Med Nucl; 2010; 29(6):312-3. PubMed ID: 20826040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
